Work

Native Mass Spectrometry in Fragment-Based Drug Discovery

Year: 2016
Type: review
Abstract: The advent of native mass spectrometry (MS) in 1990 led to the development of new mass spectrometry instrumentation and methodologies for the analysis of noncovalent protein-ligand complexes. Native MS has matured to become a fast, simple, highly sensitive and automatable technique with well-established utility for fragment-based drug discovery (FBDD). Native MS has the capability to directly detect weak ligand binding to proteins, to determine stoichiometry, relative or absolute binding affinities and specificities. Native MS can be used to delineate ligand-binding sites, to elucidate mechanisms of cooperativity and to study the thermodynamics of binding. This review highlights key attributes of native MS for FBDD campaigns.
Source: Molecules
Institution: Griffith University
Language: English
Subfield: Spectroscopy
Field: Chemistry
Open Access status: gold
Estimated APC paid: $3,258
OpenAlex ID: W2505449729
FWCI: 1.224
Cites: 106
Cited by: 87
Related to: 10